App for Acute Pain Service in Major Surgery

Sponsor
Seoul National University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT06014918
Collaborator
(none)
60
1
1
8
7.5

Study Details

Study Description

Brief Summary

The app will be installed on the patient's smartphone before surgery. Patients will receive reminders to record their pain intensity and opioid-related side effects at the pre-determined time points until at least 2 days after surgery. The patient's compliance with the reminders will be assessed. On the second postoperative day, their satisfaction with pain control and app usage will be evaluated. Patients can also provide feedback on any issues they have encountered with the app during the study period.

Condition or Disease Intervention/Treatment Phase
  • Device: A new smart device application (Smart APS)
N/A

Detailed Description

Following admission, the application will be installed on the enrolled patient's smartphone prior to surgery, and the patient will be instructed on the content of the program and how to use it. Educational videos within the app about postoperative pain control will be introduced to the patient at this time. At the pre-determined time points, until at least 2 days post-operatively, the patient will be reminded of the assessment via an alarm function and will enter post-operative pain intensity using an 11-point numeric rating scale or verbal rating scale and the presence of opioid-related side effects into the application. If a patient responds to the alarm 2 or more times per day, they will be considered to be compliant. Postoperative opioid consumption using patient-controlled analgesia and the amount of rescue analgesics will be assessed. Patients will be assessed with a survey on postoperative day 2 for overall satisfaction with pain control and usage of the application. Patients will also be able to provide feedback via the application or research staff on any errors or inconveniences they may have experienced while using the application throughout the study.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
This study is designed to examine the feasibility of a smart device application to assess and manage postoperative pain in a single group of patients undergoing major surgery.This study is designed to examine the feasibility of a smart device application to assess and manage postoperative pain in a single group of patients undergoing major surgery.
Masking:
None (Open Label)
Masking Description:
As this is an observational study to assess feasibility, the participants, care providers, researchers, and outcome assessors cannot be masked by the nature of the design.
Primary Purpose:
Supportive Care
Official Title:
A Smart Device Application for Acute Pain Service in Patients Undergoing Major Surgery: A Prospective Observational Feasibility Study
Actual Study Start Date :
Aug 28, 2023
Anticipated Primary Completion Date :
Feb 28, 2024
Anticipated Study Completion Date :
Apr 28, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Patients using a new application

Patients will enter pain intensity and opioid analgesic side effects using a new application named 'Smart APS', developed for acute pain services, and later assess for adherence and satisfaction with the application use.

Device: A new smart device application (Smart APS)
The application sends alarms to patients to enter their pain intensity and opioid-related side effects at the times set by the researcher. Additional entries for severe pain or opioid side effects are also available at any other time. Researchers can monitor the results in real-time via an integrated web program. If a red flag sign is observed during regular office hours, an anesthesiologist participating in the research will visit the patient for assessment and intervention. In addition, patients can watch pre-made perioperative pain-related educational videos through the smart APS.

Outcome Measures

Primary Outcome Measures

  1. Patients' adherence rate to Smart APS [Postoperative day 1 and 2]

    Proportion of patients who successfully used the smart APS among all patients.. Through Smart APS, a self-assessment is conducted three times a day, and it is assumed that the application has been used successfully if the patient completes an evaluation of pain intensity and opioid analgesic side effects at least twice on the first and second days after surgery.

Secondary Outcome Measures

  1. Patient satisfaction with pain management [Postoperative day 2]

    Patient satisfaction with pain management using the 'Smart APS' app, rated on an 11-point scale (0 to 10 points, a higher number indicates higher satisfaction).

  2. Patient satisfaction with application usage [Postoperative day 2]

    A survey of patient satisfaction with the use of the 'Smart APS' app, consisted of 6 questions which are rated on a 7-point scale.

Other Outcome Measures

  1. Number of spontaneous assessments [Whole study period (from the day of surgery to at least 2 days after surgery)]

    The number of spontaneous assessments made by the participant outside of the scheduled assessment time.

  2. Amount of analgesics used [Whole study period (from the day of surgery to at least 2 days after surgery)]

    Total volume of patient-controlled analgesia used and rescue analgesics.

  3. Patient satisfaction with the provided audio-visual educational materials [Postoperative day 2]

    Patient satisfaction with the provided four audio-visual materials is evaluated on a 0-10 scale. (A higher score indicates higher satisfaction)

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients aged 19 to 70 years who are scheduled for regular major surgery

  • American Society of Anesthesiologists (ASA) physical status classification I or II

  • Patients who are using a smartphone and are not expected to have any restrictions on application use

Exclusion Criteria:
  • Unable to communicate

  • Patients under the age of 19 and over the age of 70

  • Patients who, in the opinion of the investigator or study staff, are not appropriate for this study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Seoul National University Hospital Seoul Korea, Republic of KS013

Sponsors and Collaborators

  • Seoul National University Hospital

Investigators

  • Principal Investigator: Hojin Lee, PhD, Seoul National University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hojin Lee, MD, Associate professor, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT06014918
Other Study ID Numbers:
  • 2304-053-1420
First Posted:
Aug 28, 2023
Last Update Posted:
Aug 30, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 30, 2023